Cover Image
Market Research Report

Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services); and Geography

Published by The Insight Partners Product code 819812
Published Content info 159 Pages
Delivery time: 1-2 business days
Price
Back to Top
Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services); and Geography
Published: March 8, 2019 Content info: 159 Pages
Description

The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is estimated to grow with a CAGR of 12.2% from 2019-2027.

The market is driven by the factors such as, increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices. However, the challenge such as lack of skilled professionals for CMO likely to impact the growth of the market in the forecast period.

Increasing patent cliffs are likely to grow market dynamically. The rising numbers of the contract manufacturing across the globe are entering in the production of the generic drugs as the legislation encouraged competition to benefit consumers. The CMOs help in the manufacturing the drug with the bioequivalence testing and the drugs are produced with the current good manufacturing practices. The CMO allows to reduce the cost of manufacturing and enhance the production in bulk quantities. Additionally as per the paper's statistics it is stated that approximately US$ 194 billion in the innovative drugs sales are at risk during the 2017- 2020. Also an estimate of nearly US$ 31 billion could be lost due to the expiry of patents alone in 2018. Therefore, owing to the above mentioned factors the market for the healthcare CMO is likely to propel during the forecast period.

Global healthcare CMO market, based on service was segmented into major segments such as pharmaceutical contract manufacturing services and medical device contract manufacturing services. The pharmaceutical contract manufacturing services segment is expected to dominate the market in 2027, owing to the advantages provided by the contract manufacturing organizations and he rising prevalence of chronic and acute disease across the world. In addition, the segment is also anticipated to witness the fastest growth rate during the forecast period, 2018 to 2027.

Some of the major primary and secondary sources included in the report for the healthcare CMO market are Indian Drug Manufacturers' Association, International Trade Administration, Japan CMO Association, Medicines and Healthcare products Regulatory Agency, Ministry of Health and Saudi Pharmaceutical Industries & Medical Appliances Corporation among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the healthcare CMO market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global healthcare CMO market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00003263

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3 MARKET SEGMENTATION
    • 1.3.1 Global Healthcare CMO Market - By Service
    • 1.3.2 Global Healthcare CMO Market - By Geography

2. GLOBAL HEALTHCARE CMO MARKET - KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

    • 3.1.1 Coverage
    • 3.1.2 Secondary Research
    • 3.1.3 Primary Research

4. GLOBAL HEALTHCARE CMO- MARKET LANDSCAPE

  • 4.1 OVERVIEW
  • 4.2 PEST ANALYSIS
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & South Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis

5. GLOBAL HEALTHCARE CMO MARKET - KEY MARKET DYNAMICS

  • 5.1 KEY MARKET DRIVERS
    • 5.1.1 Increasing Inclination of Pharmaceutical and Medical Device Manufacturers Towards Outsourcing
    • 5.1.2 Increasing Patent Cliffs
    • 5.1.3 Rising Geriatric Population Coupled With The Increasing Production of Drug s& Medical Devices
  • 5.2 KEY MARKET CHALLENGES
    • 5.2.1 Lack of Skilled Professionals for CMO
  • 5.3 KEY MARKET OPPORTUNITIES
    • 5.3.1 Rising Demand in Developing Regions
    • 5.3.2 Growth Opportunities Due to Biosimilars Market
  • 5.4 MARKET TREND
    • 5.4.1 Rise in Market Consolidation
  • 5.5 IMPACT ANALYSIS

6. HEALTHCARE CMO MARKET - GLOBAL ANALYSIS

  • 6.1 GLOBAL HEALTHCARE CMO MARKET REVENUE FORECASTS AND ANALYSIS
  • 6.2 GLOBAL HEALTHCARE CMO MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
  • 6.3 PERFORMANCE OF KEY PLAYERS
    • 6.3.1 Catalent, Inc.
    • 6.3.2 Lonza
    • 6.3.3 Integer Holdings Corporation
    • 6.3.4 Flex Ltd
  • 6.4 EXPERT OPINIONS

7. GLOBAL HEALTHCARE CMO MARKET ANALYSIS- BY SERVICE

  • 7.1 OVERVIEW
  • 7.2 GLOBAL HEALTHCARE CMO MARKET BY SERVICE, 2018 & 2027 (%)
  • 7.3 PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET
    • 7.3.1 Overview
    • 7.3.2 Global Pharmaceutical Contract Manufacturing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.3 Active Pharmaceutical Ingredients (API) Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Global Active Pharmaceutical Ingredients (API) Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.4 Final Dosage Form Manufacturing Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Global Final Dosage Form Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.5 Packaging Market
      • 7.3.5.1 Overview
      • 7.3.5.2 Global Packaging Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET
    • 7.4.1 Overview
    • 7.4.2 Global Medical Device Contract Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Outsourcing Design Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Global Outsourcing Design Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.4 Device Manufacturing Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Global Device Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.5 Final Goods Assembly Market
      • 7.4.5.1 Overview
      • 7.4.5.2 Global Final Goods Assembly Market Revenue and Forecasts to 2027 (US$ Mn)

8. HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

  • 8.1 NORTH AMERICA HEALTHCARE CMO MARKET
    • 8.1.1 Overview
    • 8.1.2 North America Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
    • 8.1.3 North America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 8.1.3.1 North America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.1.3.2 North America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.4 North America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
    • 8.1.5 US Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.5.1 US Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.5.2 US Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.1.5.2.1 US Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.5.2.2 US Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.6 Canada Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.6.1 Canada Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.6.2 Canada Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.1.6.2.1 Canada Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.6.2.2 Canada Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.7 Mexico Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.7.1 Mexico Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.7.2 Mexico Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.1.7.2.1 Mexico Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.7.2.2 Mexico Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.2 EUROPE HEALTHCARE CMO MARKET
    • 8.2.1 Overview
    • 8.2.2 Europe Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
    • 8.2.3 Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 8.2.3.1 Europe Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.2.3.2 Europe Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.4 Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
    • 8.2.5 Germany Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.5.1 Germany Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.5.2 Germany Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.2.5.2.1 Germany Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.5.2.2 Germany Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.6 UK Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.6.1 UK Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.6.2 UK Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.2.6.2.1 UK Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.6.2.2 UK Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.7 France Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.7.1 France Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.7.2 France Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.2.7.2.1 France Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.7.2.2 France Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.8 Spain Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.8.1 Spain Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.8.2 Spain Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.2.8.2.1 Spain Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.8.2.2 Spain Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.9 Italy Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.9.1 Italy Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.9.2 Italy Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.2.9.2.1 Italy Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.9.2.2 Italy Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.3 ASIA PACIFIC HEALTHCARE CMO MARKET
    • 8.3.1 Overview
    • 8.3.2 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
    • 8.3.3 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 8.3.3.1 Asia Pacific Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.3.3.2 Asia Pacific Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.4 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
    • 8.3.5 China Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.5.1 China Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.5.2 China Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.3.5.2.1 China Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.5.2.2 China Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.6 Japan Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.6.1 Japan Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.6.2 Japan Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.3.6.2.1 Japan Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.6.2.2 Japan Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.7 India Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.7.1 India Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.7.2 India Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.3.7.2.1 India Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.7.2.2 India Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.8 Australia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.8.1 Australia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.8.2 Australia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.3.8.2.1 Australia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.8.2.2 Australia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.9 South Korea Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.9.1 South Korea Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.9.2 South Korea Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.3.9.2.1 South Korea Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.9.2.2 South Korea Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.4 MIDDLE EAST & AFRICA HEALTHCARE CMO MARKET
    • 8.4.1 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
    • 8.4.2 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 8.4.2.1 Middle East & Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.4.2.2 Middle East & Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.4.3 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
    • 8.4.4 UAE Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.1 UAE Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.2 UAE Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.4.4.2.1 UAE Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.4.2.2 UAE Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.4.5 Saudi Arabia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.5.1 Saudi Arabia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.5.2 Saudi Arabia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.4.5.2.1 Saudi Arabia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.5.2.2 Saudi Arabia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.4.6 South Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.6.1 South Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.6.2 South Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.4.6.2.1 South Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.6.2.2 South Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.5 SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET
    • 8.5.1 Overview
    • 8.5.2 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
    • 8.5.3 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 8.5.3.1 South and Central America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.5.3.2 South and Central America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.5.4 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
    • 8.5.5 Brazil Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.5.1 Brazil Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.5.2 Brazil Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.5.5.2.1 Brazil Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.5.5.2.2 Brazil Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.5.6 Argentina Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.6.1 Argentina Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.6.2 Argentina Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
        • 8.5.6.2.1 Argentina Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.5.6.2.2 Argentina Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9. HEALTHCARE CMO MARKET -INDUSTRY LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 GROWTH STRATEGIES IN THE HEALTHCARE CMO MARKET, 2015-2018
  • 9.3 ORGANIC DEVELOPMENTS
    • 9.3.1 Overview
  • 9.4 ORGANIC GROWTH STRATEGIES IN THE HEALTHCARE CMO MARKET, 2016-2018
  • 9.5 EXPANSION
    • 9.5.1 Recent Expansion By Players in the Healthcare CMO Market, 2015-2018
  • 9.6 SERVICE LAUNCH
    • 9.6.1 Recent Service Launch By Players in the Healthcare CMO Market, 2015-2018
  • 9.7 OTHERS
    • 9.7.1 Others Organic Strategies Made by the Players in the Healthcare CMO Market, 2015-2018
  • 9.8 INORGANIC DEVELOPMENTS
    • 9.8.1 Overview
  • 9.9 INORGANIC GROWTH STRATEGIES IN THE HEALTHCARE CMO MARKET, 2015-2018
  • 9.10 AGREEMENT
    • 9.10.1 Agreement Made by the Players in the Healthcare CMO Market, 2015-2018
  • 9.11 ACQUISITION
    • 9.11.1 Acquisition Made by the Players in the Healthcare CMO Market, 2015-2018
  • 9.12 PARTNERSHIPS
    • 9.12.1 Recent Partnership by Players in the healthcare CMO Market, 2015-2018
  • 9.13 COLLABORATION
    • 9.13.1 Collaboration By Players in the Healthcare CMO Market, 2015-2018

10. HEALTHCARE CMO MARKET-KEY COMPANY PROFILES

  • 10.1 ROYAL DSM
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 CATALENT, INC
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Financial Overview
    • 10.2.4 Service Portfolio
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Financial Overview
    • 10.3.4 Service Portfolio
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 RECIPHARM AB (PUBL)
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Financial Overview
    • 10.4.4 Service Portfolio
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 FAREVA
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Financial Overview
    • 10.5.4 Service Portfolio
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 LONZA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Financial Overview
    • 10.6.4 Service Portfolio
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 PIRAMAL ENTERPRISES LTD.
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Financial Overview
    • 10.7.4 Service Portfolio
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 DR. REDDY'S LABORATORIES LTD.
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Financial Overview
    • 10.8.4 Service Portfolio
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 ALMAC GROUP
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Financial Overview
    • 10.9.4 Service Portfolio
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 FAMAR HEALTH CARE SERVICES
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Financial Overview
    • 10.10.4 Service Portfolio
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. APPENDIX

  • 11.1 ABOUT THE INSIGHT PARTNERS
  • 11.2 GLOSSARY OF TERMS

LIST OF TABLES

  • TABLE 1. R&D INVESTMENTS BY MAJOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES
  • TABLE 2. CONSOLIDATION IN PHARMACEUTICAL & MEDICAL DEVICE COMPANIES
  • TABLE 3. NORTH AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 4. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 5. NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 6. US HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 7. US PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 8. US MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 9. CANADA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 10. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 11. CANADA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 12. MEXICO HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 13. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 14. MEXICO MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 15. EUROPE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 16. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 17. EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 18. GERMANY HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 19. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 20. GERMANY MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 21. UK HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 22. UK PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 23. UK MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 24. FRANCE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 25. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 26. FRANCE MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 27. SPAIN HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 28. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 29. SPAIN MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 30. ITALY HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 31. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 32. ITALY MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 33. ASIA PACIFIC HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 34. ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 35. ASIA PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 36. CHINA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 37. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 38. CHINA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 39. JAPAN HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 40. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 41. JAPAN MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 42. INDIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 43. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 44. INDIA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 45. AUSTRALIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 46. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 47. AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 48. SOUTH KOREA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 49. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 50. SOUTH KOREA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 51. MIDDLE EAST & AFRICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 52. MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 53. MIDDLE EAST & AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 54. UAE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 55. UAE PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 56. UAE MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 57. SAUDI ARABIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 58. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 59. SAUDI ARABIA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 60. SOUTH AFRICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 61. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 62. SOUTH AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 63. SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 64. SOUTH AND CENTRAL AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 65. SOUTH AND CENTRAL AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 66. BRAZIL HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 67. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 68. BRAZIL MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 69. ARGENTINA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY SERVICE (US$ MN)
  • TABLE 70. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 71. ARGENTINA MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 72. RECENT EXPANSION BY PLAYERS IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 73. RECENT SERVICE LAUNCH BY PLAYERS IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 74. OTHERS ORGANIC STRATEGIES MADE BY THE PLAYERS IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 75. AGREEMENT MADE BY THE PLAYERS IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 76. ACQUISITION MADE BY THE PLAYERS IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 77. RECENT PARTNERSHIP IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 78. COLLABORATION IN THE HEALTHCARE CMO MARKET, 2015-2018
  • TABLE 79. GLOSSARY OF TERMS, HEALTHCARE CMO MARKET

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CMO MARKET SEGMENTATION
  • FIGURE 2. HEALTHCARE CMO SEGMENTATION, BY REGION
  • FIGURE 3. ASIA PACIFIC HEALTHCARE CMO MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
  • FIGURE 4. GLOBAL HEALTHCARE CMO MARKET BY SERVICE, MARKET SHARE (%), 2018
  • FIGURE 5. NORTH AMERICA PEST ANALYSIS
  • FIGURE 6. EUROPE PEST ANALYSIS
  • FIGURE 7. ASIA PACIFIC PEST ANALYSIS
  • FIGURE 8. MIDDLE EAST & SOUTH AFRICA PEST ANALYSIS
  • FIGURE 9. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
  • FIGURE 10. NUMBER OF APPROVALS FOR NDA & BLA (2005 TO 2016)
  • FIGURE 11. HEALTHCARE CMO MARKET IMPACT ANALYSIS OF DRIVER AND CHALLENGES
  • FIGURE 12. GLOBAL HEALTHCARE CMO MARKET - REVENUE FORECASTS AND ANALYSIS -2017- 2027
  • FIGURE 13. GLOBAL HEALTHCARE CMO MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027
  • FIGURE 14. GLOBAL HEALTHCARE CMO MARKET, BY SERVICE 2018 & 2027 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING SERVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 17. GLOBAL FINAL DOSAGE FORM MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 18. GLOBAL PACKAGING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 19. GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 20. GLOBAL OUTSOURCING DESIGN MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 21. GLOBAL DEVICE MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 22. GLOBAL FINAL GOODS ASSEMBLY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 23. NORTH AMERICA HEALTHCARE CMO MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 24. NORTH AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 25. NORTH AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 26. US HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 27. CANADA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 28. MEXICO HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 29. EUROPE HEALTHCARE CMO MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 30. EUROPE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 31. EUROPE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 32. GERMANY HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 33. UK HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 34. FRANCE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 35. SPAIN HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 36. ITALY HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 37. ASIA PACIFIC HEALTHCARE CMO MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 38. ASIA PACIFIC HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 39. ASIA PACIFIC HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 40. CHINA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 41. JAPAN HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 42. INDIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 43. AUSTRALIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 44. SOUTH KOREA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 45. MIDDLE EAST & AFRICA HEALTHCARE CMO MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 46. MIDDLE EAST & AFRICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 47. MIDDLE EAST & AFRICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 48. UAE HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 49. SAUDI ARABIA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 50. SOUTH AFRICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 51. SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 52. SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 53. SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 54. BRAZIL HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 55. ARGENTINA HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 56. GROWTH STRATEGIES IN THE HEALTHCARE CMO MARKET, 2015-2018
  • FIGURE 57. ORGANIC GROWTH STRATEGIES IN THE HEALTHCARE CMO MARKET, 2016-2018
  • FIGURE 58. INORGANIC DEVELOPMENTS IN THE HEALTHCARE CMO MARKET, 2015-2018
Back to Top